Gland Pharma Ltd (NSE:GLAND)
₹ 1777.6 -26.2 (-1.45%) Market Cap: 292.86 Bil Enterprise Value: 266.83 Bil PE Ratio: 42.33 PB Ratio: 3.33 GF Score: 82/100

Q1 2024 Gland Pharma Ltd Earnings Call Transcript

Aug 07, 2023 / 02:00PM GMT
Release Date Price: ₹1342.55 (+0.53%)
Operator

Ladies and gentlemen, good day, and welcome to the Gland Pharma Limited Q1 FY '24 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Sumanta Bajpayee.

Sumanta Bajpayee
Gland Pharma Limited - VP of IR

Thank you. Good evening, everyone. Warm welcome to Gland Pharma's earnings conference call for first quarter of financial year 2024. I have with me Mr. Srinivas Sadu, MD and CEO; Mr. Ravi Shekhar Mitra, our CFO, to discuss business performance and to answer the queries during the call. We will begin the call with the business highlights and overview by Mr. Sadu, followed by financial overview by Mr. Mitra. After opening remarks from management, operator will open the bridge for Q&A session. Our earnings presentation has been submitted to the stock exchanges and is also available on our website.

Before we proceed with the call, please note, some of the statements made in today's discussion may be forward-looking in nature and are based on management

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot